ArticlePDF Available

A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief after laparoscopic cholecystectomy: A prospective, randomised, double blind and placebo controlled study

Authors:

Abstract and Figures

Background and Aims Intraperitoneal local anaesthetic instillation (IPLAI) reduces postoperative pain and analgesic consumption effectively but the timing of instillation remains debatable. This study aims at comparing pre-emptive versus post-surgery IPLA in controlling postoperative pain after elective laparoscopic cholecystectomy. Methods Ninety patients belonging to American Society of Anesthesiologists physical status I or II were randomly assigned to receive IPLAI of either 30 ml of normal saline (C) or 30 ml of 0.5% bupivacaine at the beginning (PE) or at the end of the surgery (PS) using a double-dummy technique. The primary outcome was the intensity of postoperative pain by visual analogue scale score (VAS) at 30 minute, 1, 2, 4, 6, 24 hours after surgery and time to the first request for analgesia. The secondary outcomes were analgesic request rate in 24 hours; duration of hospital stay and time to return to normal activity. Data were compared using analysis of variance, Kruskal-Wallis or Chi-square test. Results For all predefined time points, VAS in group PE was significantly lower than that in groups C (P < 0.05). The time to first analgesic request was shortest in group C (238.0 ± 103.2 minutes) compared to intervention group (PE, 409.2 ± 115.5 minutes; PS, 337.5 ± 97.5 minutes;P < 0.001). Time to attain discharge criteria was not statistically different among groups. Conclusion Pre-emptive intraperitoneal local anaesthetic instillation resulted in better postoperative pain control along with reduced incidence of shoulder pain and early resumption of normal activity in comparison to post surgery IPLAI and control.
Content may be subject to copyright.
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 1/9
Indian J Anaesth. 2019 Mar; 63(3): 205–211.
doi: 10.4103/ija.IJA_767_18
PMCID: PMC6423947
PMID: 30988535
A comparative evaluation of pre-emptive versus post-surgery
intraperitoneal local anaesthetic instillation for postoperative pain relief
after laparoscopic cholecystectomy: A prospective, randomised, double
blind and placebo controlled study
Prabhu Gnapika Putta, Hemalatha Pasupuleti, Aloka Samantaray, Hemanth Natham, and
Mangu Hanumantha Rao
Department of Anaesthesiology and Critical Care, Sri Venkateswara Institute and Medical Sciences, SVIMS
University, Tirupati, Andhra Pradesh, India
Address for correspondence: Dr. Aloka Samantaray, Department of Anaesthesiology and Critical Care, Sri
Venkateswara Institute of Medical Sciences, SVIMS University, Tirupati - 517 507, Andhra Pradesh, India. E-
mail: aloksvims@gmail.com
Copyright : © 2019 Indian Journal of Anaesthesia
This is an open access journal, and articles are distributed under the terms of the Creative Commons
Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the
work non-commercially, as long as appropriate credit is given and the new creations are licensed under the
identical terms.
Abstract
Background and Aims:
Intraperitoneal local anaesthetic instillation (IPLAI) reduces postoperative pain and analgesic
consumption effectively but the timing of instillation remains debatable. This study aims at comparing
pre-emptive versus post-surgery IPLA in controlling postoperative pain after elective laparoscopic
cholecystectomy.
Methods:
Ninety patients belonging to American Society of Anesthesiologists physical status I or II were
randomly assigned to receive IPLAI of either 30 ml of normal saline (C) or 30 ml of 0.5% bupivacaine
at the beginning (PE) or at the end of the surgery (PS) using a double-dummy technique. The primary
outcome was the intensity of postoperative pain by visual analogue scale score (VAS) at 30 minute, 1,
2, 4, 6, 24 hours after surgery and time to the first request for analgesia. The secondary outcomes were
analgesic request rate in 24 hours; duration of hospital stay and time to return to normal activity. Data
were compared using analysis of variance, Kruskal-Wallis or Chi-square test.
Results:
For all predefined time points, VAS in group PE was significantly lower than that in groups C (P <
0.05). The time to first analgesic request was shortest in group C (238.0 ± 103.2 minutes) compared to
intervention group (PE, 409.2 ± 115.5 minutes; PS, 337.5 ± 97.5 minutes;P < 0.001). Time to attain
discharge criteria was not statistically different among groups.
Conclusion:
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 2/9
Pre-emptive intraperitoneal local anaesthetic instillation resulted in better postoperative pain control
along with reduced incidence of shoulder pain and early resumption of normal activity in comparison
to post surgery IPLAI and control.
Key words: Analgesia, bupivacaine, cholecystectomy, intraperitoneal, laparoscopy
INTRODUCTION
The origin of pain after laparoscopic cholecystectomy is multifactorial -pain arising from incision sites
i.e., somatic pain, pain from gall bladder bed i.e., visceral pain and referred pain to shoulder.[1] The
most explainable cause for visceral and shoulder pain is peritoneal distension and visceral irritation
caused by the creation of capnoperitoneum and surgical handling. Intraperitoneal administration of
local anaesthetic agents alone or in combination with opioids has been found to reduce the
postoperative pain and analgesic consumption effectively following laparoscopic cholecystectomy.[2,3]
However, the timing remains debatable.[4] Recent advances suggest that an afferent block (with local
anaesthetics) achieved before nociceptive input can reduce or eliminate the onset of central neural
hyper excitability and can thus significantly reduce both intensity and duration of pain, while also
delaying its onset.[5] We hypothesised that local anaesthetic instillation into the peritoneal cavity
immediately after capnoperitoneum (equivalent to pre-emptive analgesia) would be more efficient than
at the end of the surgery (equivalent to post nociceptive analgesia) in controlling postoperative pain and
discomfort and thus lead to an earlier discharge from the hospital.
METHODS
This prospective randomised double blind, double dummy trial was conducted after obtaining approval
from Institutional Ethics committee and written informed consent from the study participants.
The study population comprised of 90 patients belonging to American Society of Anesthesiologists
physical status (ASA PS) I and II in the age group of 18–60 years of either sex posted for elective
laparoscopic cholecystectomy under general anaesthesia. Patients not willing to participate in the study,
pregnant or lactating mothers, allergic to study drugs, presented with acute cholecystitis, severe
cardiac, pulmonary and renal diseases were excluded from the study. Any patients who needed
conversion to open cholecystectomy or insertion of a drain at the end of the procedure were also
excluded from the study.
Ninety patients were randomised into three groups using computer generated random number table and
sealed opaque envelope technique. Each patient received intraperitoneal instillation of either 30 ml of
placebo or 0.5% bupivacaine at different timing as per their group allocation using double dummy
technique.
Patients in control group (C) received 30 ml normal saline at beginning of surgery (after creation of
capnoperitoneum) and at the end of the surgery (after removal of gall bladder). Patients from pre-
emptive group (PE) received 30 ml 0.5% bupivacaine at the beginning of surgery and 30 ml of saline at
the end of the surgery and patients from post-surgery group (PS) received 30 ml of saline at the
beginning of surgery and 30 ml of 0.5% bupivacaine at the end of the surgery. Blinding was ensured by
preparing the study drugs in a ready to inject coded 50 ml syringe by a trainee anaesthesia resident not
involved with the study protocol. The postoperative follow-up of the study participant was done by one
of the co-author blinded to the study drug administration and not involved with intraoperative
management of the case.
Preoperatively, all the patients were explained about the study protocol and how to use visual analogue
scale (VAS) to indicate their pain perception by identifying zero as no pain and 10 as worst imaginable
pain. On arrival to the operating room a peripheral 18 G intravenous cannula under local anaesthesia
was secured and standard monitoring like three lead electrocardiography, non-invasive blood pressure,
oxygen saturation and end tidal CO were connected and base line vital parameters noted. A standard
general endotracheal anaesthesia protocol comprising of intravenous (IV) fentanyl (2 μ/kg), midazolam
(0.04 mg/kg), thiopentone sodium titrated to sleep dose (4-7 mg/kg) for anaesthesia induction and
vecuronium bromide (0.1 mg/kg) IV to facilitate orotracheal intubation was followed in all patients. All
2
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 3/9
patients were given 0.1 mg/kg of morphine IV after induction of anaesthesia but before incision for
trocar placement. Anaesthesia was maintained with 1–3% sevoflurane and 40% oxygen in air.
Intermittent positive-pressure ventilation was used to adjust minute ventilation for the desired
normocapnia (end tidal carbon dioxide between 34 and 38 mm Hg). During laparoscopy, intra-
abdominal pressure was limited to 12–14 mm Hg. At the end of surgery, residual neuromuscular
blockade was reversed with intravenous neostigmine and glycopyrrolate. The study drugs as per group
allocation were instilled in equal amounts into the hepatodiaphragmatic space, near and above the
hepatoduodenal ligament and above the gall bladder bed under direct vision in Trendelenburg's
position. All patients were operated by the same surgical team with standard number of port placement
and surgical steps. All patients received 4 mg dexamethasone IV after anaesthesia induction and 8 mg
ondansetron after deflation of capnoperitoneum as prophylaxis for post-operative nausea and vomiting.
The intensity of pain was recorded for all patients using visual analogue scale at 0.5, 1, 2, 4, 6, 24 hours
after surgery. Analgesia requirements were recorded for 24 h. If VAS score >3, patients were prescribed
paracetamol 1 g IV followed by additional doses if requested by patient after an interval of 6 h and pain
between 2 doses of paracetamol was treated with fentanyl 1 μg/kg IV (rescue analgesic). Time to
satisfy criteria for hospital discharge was assessed by modified post anaesthesia discharge scoring
system (PADSS) criteria[6] at 8.00 h and 18.00 h every day until they achieved a score of at least 9 out
of 10.
The primary outcome measure of the trial was total postoperative pain severity and time to the first
analgesic request in recovery room (considering time at extubation to be zero).
The secondary outcomes were analgesic request rate (number of doses of paracetamol in 24 hours);
number of patient using rescue fentanyl in 24 hours; duration of hospital stay (PADSS of 9/10),
incidence of shoulder pain and return to normal activity (obtained by telephonic interview).
Sample size was estimated from our pilot study which yielded a mean pain score of 4.6 with standard
deviation 2.7 at second hour after surgery measured with a visual analogue scale in 10 patients who
received normal saline. In order to demonstrate a 25 mm difference in VAS score 2 h after surgery
among the groups for an alpha-error of 0.05 and beta-error of 0.10, we needed 25 patients per group.
Assuming a dropout rate of 15%, 90 patients were required for this study.
The data obtained were evaluated for normality using the Shapiro–Wilk test. Normally distributed data
were presented as mean (SD). Comparison of three groups for continuous variables were done by using
analysis of variance followed by a post hoc Tukey test to find out the significance between pairs. Non-
normally distributed continuous variables were expressed as a median value (inter quartile range 25–
75) and was analysed using Kruskal–Wallis test with Bonferroni's correction. Descriptive variables
were presented as frequency of occurrence, percentage or number and compared using Chi-square test
or Fisher's exact test, as appropriate; P values <0.05 was considered statistically significant. All the
data were checked twice. All statistical analysis were done using SPSS version 19 (IBM Inc. Chicago
IL, USA, 2010).
RESULTS
In total 134 patients were screened for the study and 90 patients meeting the inclusion and not having
any exclusion criteria were randomised into three groups. There were six dropouts after randomisation,
two from each group as they needed drain insertion at the end of surgery for suspected bile spillage [
Figure 1]. There were no significant differences among the three treatment groups in terms of patient
demographics and risk stratification except that patients from control group underwent longer duration
of surgery [Table 1].
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 4/9
Open in a separate window
Figure 1
CONSORT Flow Diagram
Table 1
Patients’ baseline and intraoperative characteristics
Variable Control (C) n=30 Pre-emptive (PE) n=30 Post-surgery (PS) n=30 P
Age (yrs.) 41.0 (9.0) 46.7 (8.7) 41.6 (12.7) 0.080
Sex (Male/Female) (n) 13/15 11/17 9/19 0.540
Weight (kgs) 61 (11) 63.2 (10.7) 60.17 (8.8) 0.520
BMI (kg/m ) 24.2 (3.2) 25.0 (4.0) 24.2 (3.2) 0.660
ASA PS I/II (n) 23/5 18/10 21/7 0.310
Duration of surgery (min) 106.6 (18.8) 87.1 (22.9) 92.6 (26.7) 0.007
Data presented as mean (SD); n – Number of patients; BMI – Body mass index; ASAPS – American Society of
Anesthesiologists Physical Status
2
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 5/9
None of the patients complained pain in the first 30 minutes after surgery and there after a significant
difference in pain perception was found among groups.
All patients from control group had a higher pain score compared to intervention group (PE and PS)
from 1 hour onward till the completion of the study period for all predefined time points.
In our study, PE group achieved a statistically significant lower VAS score for all time points over
control whereas for PS group it reached statistical significance only at 4 and 24 hour [Table 2]. The
time to first analgesic request was shortest in group C (238.0 ± 103.2 minutes) compared to
intervention group (PE, 409.2 ± 115.5 minutes; PS, 337.5 ± 97.5 minutes; P < 0.001). However, the PE
group fairs better than PS group in delaying the time to first analgesic request by about 20% over the
post-surgery group (P = 0.039 by post-hoc test) [Table 2]. A statistically significant, reduction of
incidence of shoulder tip pain was found at 24 hour post operatively in intervention groups compared
to group C (P < 0.001). Maximum number of patients (18 out of 28, 64%) from control group
experienced shoulder tip pain in the postoperative period in contrast to only 7% (2 out of 28) from PE
and 21% (6 out of 28) from PS [Table 3].
Table 2
Primary outcome measures
Primary Outcome variables Control (C)
n=28
Pre-emptive (PE)
n=28
Post-surgery (PS)
n=28
P
VAS 30 min 0 (0) 0 (0) 0 (0)
VAS 1 h 0 (0-2) 0 (0-0) 0 (0-2) 0.004
VAS 2 h 2.3 (1.4) 1.5 (1.3) 1.7 (0.9) 0.049
VAS 4 h 3.8 (1.3) 2.4 (1.3) 2.9 (1.2) <0.001
VAS 6 h 4.2 (1.3) 3.2 (0.7) 3.7 (1.4) 0.016
VAS 24 h 4.6 (1.0) 3.9 (0.8) 3.8 (0.9) 0.005
Time to the first request of analgesia
(min)
238.0 (103.2) 409.2 (115.5) 337.5 (97.5) <0.001
Data are presented as mean (SD) or median (Inter quartile range 25-75); n – Number of patients; VAS – Visual
analogue score (0-100 mm); Data analysed using Kruskal-Wallis test; P<0.05 versus control group; P<0.05
versus PS
st
th th
a b
b
b b
b
b b
b,c b
a b c
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 6/9
Table 3
Secondary Outcome measures
Secondary outcome variables Control (C)
n=28
Pre-emptive (PE)
n=28
Post-surgery (PS)
n=28
P
Number of doses of paracetamol
required
3.7 (0.5) 2.2 (0.8) 2.8 (0.7) <0.001
Need for rescue analgesics, n (%) 16 (57%) 2 (7%) 7 (25%) <0.001
Incidence of shoulder pain, n18 (64%) 2 (7%) 6 (21%) <0.001
Time to satisfy modified PADSS
criteria (min)
1096 (114) 1140 (181) 1088 (127) 0.357
Time to return to normal activity
(days)
6.2 (0.8) 4.7 (0.6) 5.5 (0.6) <0.001
Data presented as mean (SD) or median (quartile 1-3); n – Number of patients. Paracetamol 1 gm IV; P<0.05
versus control; P<0.05 versus PS; PADSS – Post Anaesthetic Discharge Scoring System
The control group needed a significantly more number of paracetamol in contrast to patients from
intervention group (PE and PS). Comparison among the groups revealed that, pre-emptive group
consumed least number of doses of paracetamol (2.2 ± 0.8)) versus PS group (PS, 2.8 ± 0.7; P = 0.007)
and control group (C, 3.7 ± 0.5; P < 0.001) [Table 3]. The number of patient requiring rescue fentanyl
was significantly higher in the control group compared to intervention groups (PE and PS). Sixteen
patients from control group, two patients from pre-emptive group and seven patients from post-surgery
group required rescue fentanyl for pain relief (P < 0.001) [Table 3].
The time to achieve a score of ≥9 in PADSS was comparable among the three groups. However, the
patients from control group took longer time to resume their normal activity after discharge in
comparison to other two pre-emptive and post-surgery group (C, 6.2 ± 0.8 days; PE, 4.7 ± 0.6 days; PS,
5.5 ± 0.6 days; P < 0.001). Further post hoc analysis revealed that pre-emptive group patients returned
to their normal activity significantly much earlier compared to post surgery (PE, 4.7 ± 0.6 day; PS, 5.5
± 0.6 day; P = 0.001) and control group (PE, 4.7 ± 0.6 days C, 6.2 ± 0.8 days; P < 0.001). A similar
trend was also observed between post-surgery versus control group (PS, 5.5 ± 0.6 days; C, 6.2 ± 0.8
days P = 0.003) [Table 3].
DISCUSSION
Even today the postoperative pain after laparoscopic cholecystectomy remains one of the major
concerns while considering early discharge of patients from hospital and resumption of daily normal
activity after discharge.
The primary findings of the studies are Intraperitoneal local anaesthetic instillation (IPLAI) of
bupivacaine after creation of capnoperitoneum not only reduce the postoperative pain intensity in the
first 24 h effectively but also result in early return to normal routine activity and reduce incidence of
shoulder tip pain significantly. However, intraperitoneal infiltration of bupivacaine does not lead to
early discharge from the hospital.
Two successive Cochrane review published in the same year opined that IPLAI reduces the intensity of
pain perception in ASA PS I or II patients undergoing elective laparoscopic cholecystectomy.[3,7] The
second Cochrane review[3] did not find enough evidence to determine conclusively the effects of
timing of IPLAI or different drugs on postoperative pain. However, both the review suggested that,
a
b,c b
b,c b
a b
c
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 7/9
there is a need to link the clinical relevance of this reduction in pain with IPLAI to clinical outcomes in
terms of attaining early discharge criteria and time to return to routine activity. Few recent studies also
not analysed the effects of improved pain relief on attaining early discharge criteria or resumption of
daily routine activity.[8,9,10]
Our study was designed to overcome few of the shortcoming of the trials included in the previous
systemic meta-analysis. We have prospectively studied not only the effects of timings of IPLAI on pain
score but also the effect of improved pain relief on the clinical outcome in terms of attaining early
discharge criteria and time to resume normal activity. In our study, pre-emptive group achieved a
statistically significant lower VAS score at all-time points over control whereas for PS group it reached
statistical significance only at 4 and 24 hour. Nevertheless, the VAS always remained numerically
lower in PS group compared to control group. However, we did not find any significant difference in
VAS score between PE versus PS group at any time points. This improved quality of analgesia resulted
in prolongation of time to first analgesic request in the pre-emptive group by 70% over control group
and 20% over PS group [Table 2]. As a consequence of this improved duration of analgesia PE group
not only consumed less paracetamol but also less rescue analgesics compared to group C and group PS.
A meta-analysis from United Kingdom favoured use of IPLAI to reduce early postoperative pain after
laparoscopic cholecystectomy.[2] However, most of the studies included in this meta-analysis failed to
document the effect of intraperitoneal local anaesthetic instillation on postoperative shoulder pain
which is a well-recognised disturbing element with incidence of 30–50% in the postoperative period
following laparoscopic cholecystectomy. The other strong point in our study is that the incidence of
shoulder pain significantly reduced in intervention group (PE and PS) in comparison to control group.
Such high incidence of shoulder pain in control group can be partly explained by the relatively
prolonged duration of surgery and partly by the absence of IPLA instillation.
In concordance with ours study, other investigators have also confirmed the superiority of pre-emptive
analgesia in controlling post-operative pain.[5,11] Several researchers used trocar site local anaesthetic
infiltration as a form of pre-emptive analgesia. An American study concluded that a simple
combination of an oral nonsteroidal anti-inflammatory pain medication and preincision local
anaesthetic infiltration is no better than placebo in controlling postoperative pain after elective
laparoscopic cholecystectomy.[12] However, other studies using trocar site infiltration along with
IPLAI concluded favourably for pre-emptive analgesia. A Turkish study demonstrated that, trocar site
local anaesthetic infiltration is more effective then IPLA instillation for postoperative analgesia and
reduction in incidence of shoulder pain.[8] The authors explained that, higher incidence of shoulder
pain in IPLA group could be because of dilution of IPLAI with placement of a routine drain to observe
potential bile leakages. The incidence of shoulder tip pain in our study is around 7–21% with IPLAI
and very similar to the Turkish study (20%). This can be explained by the fact that unlike the Turkish
study, we have excluded all the cases requiring insertion of a drain at the end of the surgery with a
suspected spillage of bile or blood. Moreover, we have used a higher dose of IPLA (30 ml of 0.5%
bupivacaine) in contrast to Turkish study (20 mL of 0.5% bupivacaine). A Canadian randomised
control trial opined that a combination of pre-emptive periportal (20 mL) and intraperitoneal (40 mL of
0.25% bupivacaine with 1:200,000 epinephrine) infiltration provides superior quality analgesia
compared to only post-operative IPLA or incisional local anaesthesia (LA) infiltration.[13] The recent
Turkish[14] and Polish study[15] also emphasised the superiority of pre-emptive analgesia with
intraperitoneal instillation of bupivacaine. In our study, we have used additional morphine (0.1 mg per
kg) before incision as an alternative to periportal infiltration of LA in other studies to provide pre-
emptive analgesia followed by IPLA instillation after creation of capnoperitoneum. Yet, our results are
similar to their findings and suggest that a single dose of morphine before incision along with 30 mL of
0.5%bupivacaine IPLA instillation offers the same benefit of combined periportal and IPLA
infiltration.
In our study, the superior quality and prolonged duration of postoperative analgesia does not got
translated to attainment of early discharge criteria (modified PADSS 9/10) and time to attain this is
comparable among our study cohort. This could be because the time to satisfy modified PADSS criteria
was assessed only at two time points (8 AM and 6 PM) every day and not continually every hour.
th th
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 8/9
Hence, we might have missed few patients who have achieved the discharge criteria much earlier
between 8 AM and 6 PM. However, on telephonic interview, the patients from pre-emptive group
reported an early resumption to their daily activity in comparison to post surgery and control group.
Although we have taken care to standardise various factors (dose/concentration/site/position during
IPLA instillation, volume of residual CO ) except timing of instillation that might influence the
benefits of IPLA instillation, one of the major limitation to this study is failure to differentiate and
characterise the type of pain experienced by the patient while obtaining VAS score. Keeping in mind
the multifactorial nature of pain after laparoscopic cholecystectomy, a nuanced analysis could have
thrown some light on differential effect of pre-emptive and post-surgery IPLA instillation on different
types of pain perception. The second limitation is we neither warmed the CO nor measured the
residual CO volume at the end. However we have taken care to maintain intra-abdominal pressure
between 12-14 mm Hg during laparoscopy and end-tidal carbon dioxide between 34-38 mm Hg just
before extubation.
CONCLUSION
To conclude intra peritoneal local anaesthetic instillation immediately after creation of
capnoperitoneum reduces the magnitude of postoperative pain, prolongs the duration of first analgesic
request, reduces analgesic consumption, reduces incidence of shoulder pain in the postoperative period
and facilitates early resumption of normal activity. The current regimen of IPLA instillation appears to
be safe but warrant further study to ascertain plasma drug concentration before making its routine use
as a part of multimodal approach to pain management.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Bisgaard T. Analgesic treatment after Laparoscopic cholecystectomy. Anesthesiology.
2006;104:835–46. [PubMed] [Google Scholar]
2. Boddy AP, Mehta S, Rhodes M. The effect of intraperitoneal local anesthesia in laparoscopic
cholecystectomy: A systematic review and meta-analysis. Anesth Analg. 2006;103:682–8. [PubMed]
[Google Scholar]
3. Kahokehr A, Sammour T, Srinivasa S, Hill AG. Systematic review and meta-analysis of
intraperitoneal local anaesthetic for pain reduction after laparoscopic gastric procedures. Br J Surg.
2011;98:29–36. [PubMed] [Google Scholar]
4. Gurusamy KS, Nagendran M, Toon CD, Guerrini GP, Zinnurogulu M, Davidson BR. Methods of
intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy. Cochrane Database Syst
Rev. 2014;25:CD009060. [PubMed] [Google Scholar]
5. Vadivelu N, Mitra S, Schermer E, Kodumudi V, Kaye AD, Urman RD. Preventive analgesia for
postoperative pain control: A broader concept. Local Reg Anesth. 2014;7:17–22. [PMC free article]
[PubMed] [Google Scholar]
6. Palumbo P, Tellan G, Perotti B, Pacilè MA, Vietri F, Illuminati G. Modified PADSS (Post
Anaesthetic Discharge Scoring System) for monitoring outpatients discharge. Ann Ital Chir.
2013;84:661–5. [PubMed] [Google Scholar]
7. Gurusamy KS, Nagendran M, Guerrini GP, Toon CD, Zinnuroglu M, Davidson BR. Intraperitoneal
local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic
cholecystectomy. Cochrane Database Syst Rev. 2014;13:CD007337. [PubMed] [Google Scholar]
2
2
2
7/25/2019
A comparative evaluation of pre-emptive versus post-surgery intraperitoneal local anaesthetic instillation for postoperative pain relief
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423947/ 9/9
8. Altuntaş G, Akkaya ÖT, Özkan D, Sayın MM, Balas Ş, Özlü E. Comparison of intraabdominal and
trocar site local anaesthetic infiltration on postoperative analgesia after laparoscopic cholecystectomy.
Turk J Anaesthesiol Reanim. 2016;44:306–11. [PMC free article] [PubMed] [Google Scholar]
9. Jamal A, Usmani H, Khan MM, Rizvi AA, Siddiqi MM, Aslam M. Intraperitoneal pre-insufflation
of 0.125% bupivacaine with tramadol for postoperative pain relief following laparoscopic
cholecystectomy. J Anaesthesiol Clin Pharmacol. 2016;32:257–60. [PMC free article] [PubMed]
[Google Scholar]
10. Yadava A, Rajput SK, Katiyar S, Jain RK. A comparison of intraperitoneal bupivacaine-tramadol
with bupivacaine-magnesium sulphate for pain relief after laparoscopic cholecystectomy: A
prospective, randomised study. Indian J Anaesth. 2016;60:757–62. [PMC free article] [PubMed]
[Google Scholar]
11. Palmes D, Röttgermann S, Classen C, Haier J, Horstmann R. Randomized clinical trial of the
influence of intraperitoneal local anaesthesia on pain after laparoscopic surgery. Br J Surg.
2007;94:824–32. [PubMed] [Google Scholar]
12. Newcomb W, Lincourt A, Hope W, Schmelzer T, Sing R, Kercher K, et al. Prospective, double-
blinded, randomized, placebo-controlled comparison of local anesthetic and nonsteroidal anti-
inflammatory drugs for postoperative pain management after laparoscopic surgery. Am Surg.
2007;73:618–24. [PubMed] [Google Scholar]
13. Lee IO, Kim SH, Kong MH, Lee MK, Kim NS, Choi YS, et al. Pain after laparoscopic
cholecystectomy: The effect and timing of incisional and intraperitoneal bupivacaine. Can J Anaesth.
2001;48:545–50. [PubMed] [Google Scholar]
14. Karaaslan D, Sivaci RG, Akbulut G, Dilek ON. Preemptive analgesia in laparoscopic
cholecystectomy: A randomized controlled study. Pain Pract. 2006;6:237–41. [PubMed]
[Google Scholar]
15. Barczyński M, Konturek A, Herman RM. Superiority of preemptive analgesia with intraperitoneal
instillation of bupivacaine before rather than after the creation of capnoperitoneum for laparoscopic
cholecystectomy: A randomized, double-blind, placebo-controlled study. Surg Endosc. 2006;20:1088–
93. [PubMed] [Google Scholar]
Articles from Indian Journal of Anaesthesia are provided here courtesy of Wolters Kluwer -- Medknow
Publications
... 11 A systemic review and meta-analysis conducted by Shaun et al and few other study authors concluded that pre-emptive analgesia instilled intraperitonealy decreased pain post-operatively as compared to placebo and post-operative infiltration. [12][13][14][15] . Barczyński et al. compared the intraperitoneal instillation of LA pre-emptively with intraperitoneal instillation of LA at completion of surgery. ...
Article
Objective: To compare the effects of preemptive intraperitoneal instillation of local anesthetic (lignocaine) with conventional instillation after the removal of gall bladder in elective laparoscopic cholecystectomy. Study Design: Quasi-experimental study. Place and Duration of study: General Surgical ward, Combined Military Hospital, Rawalpindi Pakistan, from Jan to Apr 2018. Methodology: Patients fulfilling the inclusion criteria were randomly assorted into two groups. Group A received intraperitoneal lignocaine at the conventional timing where was in Group B local anesthetic was instilled preemptively at the time of insertion of trocar. Post operatively pain was measure on visual analogue scale at 3,6 and 12 hours. Results: Total of 184 patients were followed up post-operatively. Mean age of patients in Group A was 44.5±13.57 years and in Group B was 46.2±13.9 years. Mean post-operative pain on visual analogue scale score for Group A was 2.53±0.73 and that for Group B was 2.0±0.66 with p-value<0.01.Conclusion: The use of preemptive instillation of local anesthetic intraperitoneal was found better as compared to conventional timing of instillation in reducing the post-operative pain in elective and uncomplicated cases of laparoscopic cholecystectomy.
... Medical practitioners have advised and used various techniques to minimize this, like preoperative administration of opioids or opioid-sparring analgesia, clonidine, preoperative pregabalin, wound site instillation of local anesthetics, and intraperitoneal irrigation with bupivacaine or ondansetron and suctioning of residual gas from the peritoneum before closure [3][4][5][6][7][8][9][10]. ...
Article
Full-text available
Objectives The objective of the study was to determine the effect of a single dose of IV dexamethasone on postoperative pain in patients after laparoscopic cholecystectomy. The outcome will be measured in the terms of mean pain score. Study design and setting This is a prospective study. We did a randomized control trial to compare the outcome in two groups. This study was conducted in the Department of Surgery, Benazir Bhutto Hospital, Rawalpindi, from December 2021 to May 2022. The total duration of the study was six months. Methodology A total of 160 patients were randomly divided into group A and group B. We performed laparoscopic cholecystectomies on all the patients under standard general anesthesia. In group A (control group), 5 mL of normal saline was injected intravenously at the time of induction of anesthesia. In group B, the dexamethasone group, the inj. dexamethasone with a dose of 0.1 mg/kg diluted in 5 mL normal saline was given intravenously at the time of induction of anesthesia. Postoperatively, the median pain score was measured using visual analog scale (VAS) at 2, 6, 12, and 24 h on a specially made proforma. The results were further stratified according to gender and age. Results The postoperative VAS in group B was significantly low compared with group A when measured at 2, 6, 12, and 24 h. It means that the median pain score was markedly less in the study group than in the placebo one, and it was statistically significant (p<0.05). Conclusion Administration of a single dose of dexamethasone preoperatively in laparoscopic cholecystectomy patients is effective to control postoperative pain.
Article
Full-text available
Laparoscopy is associated with significant hemodynamic changes due to pneumoperitoneum creation. We sought to study the effectiveness of intraperitoneal local anesthetic instillation in attenuating pneumoperitoneum-mediated hemodynamic response in patients undergoing laparoscopic cholecystectomy. This randomized study was conducted after approval from the institutional ethics committee, and 100 patients were randomly assigned to either group R (40 mL of 0.2% Ropivacaine intraperitoneally) or group N (40 mL of 0.9% normal saline intraperitoneally). Data analysis was performed using SPSS version 23. Independent Samples T test was used to compare hemodynamic variables between groups at regular intervals. Statistical significance was set less than 0.05. : Heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial blood pressure were significantly lower in Group R than in Group N at 15,30, 45,60,75, and 90 min (P<0.05). : Intra peritoneal instillation of 0.2% Ropivacaine in laparoscopic cholecystectomy attenuates intra operative hemodynamic changes associated with pneumoperitoneum.
Article
Full-text available
Background: For postoperative pain relief after laparoscopic surgeries, intramuscular or intravenous non-steroidal anti-inflammatory drugs and opioids, infiltration at the incision site with local anesthetics, intraperitoneal infiltration of local anesthetics with adjuvants, epidurals and nerve blocks were in use. The study was aimed to assess the efficacy of intramuscular Tramadol and intraperitoneal instillation of bupivacaine on postoperative analgesia, postoperative nausea, and vomiting following laparoscopic cholecystectomy. Methods: This study included 60 American Society of Anesthesiologists (ASA) I and ASA II patients of aged 18-60 years who were scheduled for laparoscopic cholecystectomy under general anesthesia. 60 patients were classified randomly into two groups equally: Group T received 100 Mg of intramuscular tramadol and Group B received intraperitoneal instillation of 30 ml of plain bupivacaine. Time duration, postoperative pain, haemodynamics, nausea, vomiting, and time taken to rescue analgesia were noted. Results: The time for onset of analgesia was 6.51 ± 2.41min in group T and 7.61 ± 2.19 min in group B (p=0.039). The duration of analgesia was 2.37 ± 0.67 hours in group T and 3.65 ± 0.79 hours in group B (p=0.002). VAS Score was significantly lower in Group T than Group B at 1hr, 2hr, 4hr and 6hr (p <0.05). Intraperitoneal bupivacaine showed a significant reduction in postoperative pain for the first 6 hours postoperatively (P<0.05), and time taken to rescue analgesia requirement was prolonged (P<0.05). The rescue analgesia consumption of Paracetamol was 1.5 grams in group-B and 2.5 grams in group T (P<0.05) in 24 hr post-surgery. Nausea and vomiting were observed in 2 cases, and shoulder pain in one case in group T. Conclusion: Bupivacaine is effective in reducing postoperative pain, and it prolongs the requirement time for rescue analgesia after LC surgery. It also required less consumption of rescue analgesic without fluctuations in hemodynamics
Article
Full-text available
Backgrounds: To observe the effect of using mild intraoperative hyperventilation on the incidence of postlaparoscopic shoulder pain (PLSP) in patients undergoing laparoscopic sleeve gastrectomy. Methods: Eighty patients undergoing laparoscopic sleeve gastrectomy, aged 22 to 36 years, with American Society of Anesthesiologists grade I or II, were divided into 2 groups according to method of random number table. A mild hyperventilation was used in group A with controlling pressure of end-tidal carbon dioxide (PETCO2) of 30 to 33 mm Hg, while conventional ventilation was used in group B with PETCO2 35 to 40 mm Hg during the operation. The incidence and severity of PLSP, dosage of remedial analgesia and adverse reactions such as nausea and vomiting at 12, 24, 48, 72 hours and 1 week after surgery were recorded. Arterial blood gas was recorded before anesthesia induction, 20 minutes after pneumoperitoneum, during suture skin, and 24 hours after surgery. Results: Compared with 12, 24, 48, and 72 hours after operation, the incidence of PLSP at 1 week decreased significantly (P < .01). Compared with group B, the incidence of PLSP, pain score, and dosage of remedial analgesic at 12, 24,48, 72 hours, and 1 week after surgery were significantly decreased (P < .01). There was no significant difference between the 2 groups in arterial blood gas analysis before anesthesia induction, 20 minutes after pneumoperitoneum, during suture skin, and 24 hours after surgery (P > .05). There were no significant difference of the occurrence of adverse reactions such as nausea and vomiting between the 2 groups within 1 week after surgery (P > .05). Conclusion: Mild hyperventilation can reduce the incidence and severity of PLSP after laparoscopic sleeve gastrectomy without increasing the associated adverse effects.
Article
Full-text available
Background and aims: Post-laparoscopic shoulder pain (PLSP) is a common problem. It is a referred type of pain resulting from irritation of phrenic nerve endings. Multiple manoeuvres were used to decrease its incidence with varying success rates. In this study, we tested the use of mild intraoperative hyperventilation to reduce PLSP in patients undergoing laparoscopic sleeve gastrectomy surgery (LSG). Methods: Consenting American Society of Anesthesiologists-I and II patients undergoing LSG under general anaesthesia were randomly assigned to two groups. Group A (53 patients) received intraoperative mild hyperventilation with target end-tidal carbon dioxide (ETCO2) of 30-32 mmHg. Group B (51 patients) received conventional ventilation (ETCO2 of 35-40 mmHg). Incidence and severity of PLSP, cumulative analgesic requirements and incidence of nausea and vomiting were recorded at 12 and 24 hours postoperatively and then followed up after discharge over the phone at 48 hours, 1 week, 1 month and 3 months. Statistical significance of differences between the two groups was defined at P < 0.05. Results: Incidence of PLSP was comparable between the two groups in the first 24 hours. The intervention group had a significantly lower incidence of PLSP throughout the remaining assessment points (56.6% vs. 80.4%, 30.2% vs. 78.4%, 15.1% vs. 70.6%, 3.8% vs. 35.3% at 36 hours, 48 hours, 1 week and 1 month, respectively, P < 0.05). The average PLSP pain score was significantly lower in the mild hyperventilation group at all assessment time points. Nausea and vomiting were non-significantly lower in the mild hyperventilation group. Conclusion: Mild intraoperative hyperventilation could be beneficial in reducing the incidence and severity of PLSP after LSG surgery.
Article
Full-text available
Background Pain is one of the important reasons for delayed discharge after laparoscopic cholecystectomy. Use of intraperitoneal local anaesthetic for laparoscopic cholecystectomy may be a way of reducing pain. A previous version of this Cochrane Review found very low‐certainty evidence on the benefits and harms of the intervention. Objectives To assess the benefits and harms of intraperitoneal instillation of local anaesthetic agents in people undergoing laparoscopic cholecystectomy. Search methods We searched the Cochrane Hepato‐Biliary Group Controlled Trials Register, Cochrane Central Register of Controlled Trials, MEDLINE, Embase, and three other databases to 19 January 2021 together with reference checking of studies retrieved. We also searched five online clinical trials registries to identify unpublished or ongoing trials to 10 September 2021. We contacted study authors to identify additional studies. Selection criteria We only considered randomised clinical trials (irrespective of language, blinding, publication status, or relevance of outcome measure) comparing local anaesthetic intraperitoneal instillation versus placebo, no intervention, or inactive control during laparoscopic cholecystectomy, for the review. We excluded non‐randomised studies, and studies where the method of allocating participants to a treatment was not strictly random (e.g. date of birth, hospital record number, or alternation). Data collection and analysis Two review authors collected the data independently. Primary outcomes included all‐cause mortality, serious adverse events, and quality of life. Secondary outcomes included length of stay, pain, return to activity and work, and non‐serious adverse events. The analysis included both fixed‐effect and random‐effects models using RevManWeb. We performed subgroup, sensitivity, and meta‐regression analyses. For each outcome, we calculated the risk ratio (RR) or mean difference (MD) with 95% confidence intervals (CIs). We assessed risk of bias using predefined domains, graded the certainty of the evidence using GRADE, and presented outcome results in a summary of findings table. Main results Eighty‐five completed trials were included, of which 76 trials contributed data to one or more of the outcomes. This included a total of 4957 participants randomised to intraperitoneal local anaesthetic instillation (2803 participants) and control (2154 participants). Most trials only included participants undergoing elective laparoscopic cholecystectomy and those who were at low anaesthetic risk (ASA I and II). The most commonly used local anaesthetic agent was bupivacaine. Methods of instilling the local anaesthetic varied considerably between trials; this included location and timing of application. The control groups received 0.9% normal saline (69 trials), no intervention (six trials), or sterile water (two trials). One trial did not specify the control agent used. None of the trials provided information on follow‐up beyond point of discharge from hospital. Only two trials were at low risk of bias. Seven trials received external funding, of these three were assessed to be at risk of conflicts of interest, a further 17 trials declared no funding. We are very uncertain about the effect intraperitoneal local anaesthetic versus control on mortality; zero mortalities in either group (8 trials; 446 participants; very low‐certainty evidence); serious adverse events (RR 1.07; 95% CI 0.49 to 2.34); 13 trials; 988 participants; discharge on same day of surgery (RR 1.43; 95% CI 0.64 to 3.20; 3 trials; 242 participants; very low‐certainty evidence). We found that intraperitoneal local anaesthetic probably results in a small reduction in length of hospital stay (MD −0.10 days; 95% CI −0.18 to −0.01; 12 trials; 936 participants; moderate‐certainty evidence). No trials reported data on health‐related quality of life, return to normal activity or return to work. Pain scores, as measured by visual analogue scale (VAS), were lower in the intraperitoneal local anaesthetic instillation group compared to the control group at both four to eight hours (MD −0.99 cm VAS; 95% CI −1.19 to −0.79; 57 trials; 4046 participants; low‐certainty of evidence) and nine to 24 hours (MD −0.68 cm VAS; 95% CI −0.88 to −0.49; 52 trials; 3588 participants; low‐certainty of evidence). In addition, we found two trials that were still ongoing, and one trial that was completed but with no published results. All three trials are registered on the WHO trial register. Authors' conclusions We are very uncertain about the effect estimate of intraperitoneal local anaesthetic for laparoscopic cholecystectomy on all‐cause mortality, serious adverse events, and proportion of patients discharged on the same day of surgery because the certainty of evidence was very low. Due to inadequate reporting, we cannot exclude an increase in adverse events. We found that intraperitoneal local anaesthetic probably results in a small reduction in length of stay in hospital after surgery. We found that intraperitoneal local anaesthetic may reduce pain at up to 24 hours for low‐risk patients undergoing laparoscopic cholecystectomy. Future randomised clinical trials should be at low risk of systematic and random errors, should fully report mortality and side effects, and should focus on clinical outcomes such as quality of life.
Article
Full-text available
Background and aims: Despite advances in minimally invasive surgery, postoperative pain remains a concern after laparoscopic cholecystectomy. This study aims to compare the effect of intraperitoneal instillation of bupivacaine with alpha-2 agonists (dexmedetomidine and clonidine) for postoperative analgesia. Methods: One hundred and eight patients scheduled for elective laparoscopic cholecystectomy were randomised to receive either 20 mL of 0.5% bupivacaine (Group B), 20 mL of 0.5% bupivacaine with dexmedetomidine 1 μg/kg (Group BD) or 20 mL of 0.5% bupivacaine with clonidine 1 μg/kg (Group BC). Study drug made to equal volume (40 mL) was instilled before the removal of trocar at the end of surgery. Standard general endotracheal anaesthesia with intra-abdominal pressure of 12-14 mm Hg during laparoscopy was followed uniformly. The primary objective of our study was the magnitude of pain. One way analysis of variance (ANOVA) for continuous variables and Chi-square test for categorical variables was used. Results: The Numerical Rating Scale (NRS) scores for pain intensity did not show any statistical significance at any of the pre-defined time points. Time to first request for analgesia was shortest in group BC (64.0 ± 60.6 min) when compared to the other groups (B, 78.8 ± 83.4 min; BD, 112.2 ± 93.4 min; P < 0.05). Total amount of rescue fentanyl given in groups BD (16.8 ± 29.0 μg) and BC (15 ± 26.4 μg) was significantly less than B (35.7 ± 40.0 μg); P < 0.05). Conclusion: The addition of alpha-2 agonists to bupivacaine reduces the post-operative opioid consumption, and dexmedetomidine appears to be superior to clonidine in prolonging time to first analgesic request.
Article
Full-text available
Background and Aims In laparoscopic surgeries, intraperitoneal instillation of local anaesthetics and opioids is gaining popularity, for better pain relief. This study compared the quality and duration of post-operative analgesia using intraperitoneal tramadol plus bupivacaine (TB) or magnesium plus bupivacaine (MB). Methods In this study, 186 patients undergoing laparoscopic cholecystectomy were randomly divided into two groups: group TB received intraperitoneal tramadol with bupivacaine and group MB received intraperitoneal magnesium sulphate (MgSO4) with bupivacaine. The visual analogue scale (VAS) to assess pain, haemodynamic variables and side effects were noted and compared at different time points. The primary outcome was to compare the analgesic efficacy and duration of pain relief. The secondary outcomes included comparison of haemodynamic parameters and side effects among the two groups. The data analysis was carried out with unpaired Student's t-test and Chi-square test using software SPSS 20.0 version. Results The mean of VAS pain score after 1, 2, 4, 6 and 24 h of surgery was more in TB group compared to MB group, and the difference was statistically significant (P < 0.05). The total rescue analgesia consumption in 24 h after surgery was 2.4 g (mean) of paracetamol in TB group and 1.4 g (mean) of paracetamol in MB group which was statistically significant (P < 0.05). There were no statistically significant differences in the secondary outcomes. Conclusion Intraperitoneal instillation of bupivacaine-MgSO4 renders patients relatively pain-free in first 24 h after surgery, with longer duration of pain-free period and less consumption of rescue analgesic as compared to bupivacaine-tramadol combination.
Article
Full-text available
Background and aims: Laparoscopic cholecystectomy is associated with a fairly high incidence of postoperative discomfort which is more of visceral origin than somatic. Studies have concluded that the instillation of local anesthetic with opioid around gall bladder bed provides more effective analgesia than either local anesthetic or opioid alone. Material and methods: The study included 90 American Society of Anesthesiologists I-II patients of age 16-65 years scheduled for laparoscopic cholecystectomy under general anesthesia. The patients received the study drugs at the initiation of insufflation of CO2 in the intraperitoneal space by the operating surgeon under laparoscopic camera guidance over the gallbladder bed. Patients in Group T received tramadol 2 mg/kg in 30 ml normal saline, in Group B received bupivacaine 30 ml of 0.125% and in Group BT received tramadol 2 mg/kg in 30 ml of 0.125% bupivacaine intraperitoneally. Postoperative pain assessment was done at different time intervals in the first 24 h using Visual Analog Scale of 0-10 (0 = No pain, 10 = Worst pain imagined). Time to first dose of rescue analgesic and total analgesics required in the first 24 h postoperatively were also recorded. The incidence of side effects during the postoperative period was recorded. Results: Reduction in postoperative pain was elicited, at 4 and 8 h postoperatively when Group BT (bupivacaine-tramadol group) was compared with Group T (tramadol group) or Group B (bupivacaine group) (P < 0.01). There was a significantly lower requirement of analgesics during first 24 h postoperatively in Group BT compared to Group B or T but no significant difference in the intake of analgesics was noted between Groups B Group T. Time to first dose of rescue analgesic was also significantly prolonged in Group BT compared to Group B or T. The incidence of nausea and vomiting was comparable in all the study groups. Conclusions: Intraperitoneal application of bupivacaine with tramadol was a more effective method for postoperative pain control after laparoscopic cholecystectomy compared to intraperitoneal bupivacaine or tramadol alone.
Article
Full-text available
Pain from surgical procedures occurs as a consequence of tissue trauma and may result in physical, cognitive, and emotional discomfort. Almost a century ago, researchers first described a possible relationship between intraoperative tissue damage and an intensification of acute pain and long-term postoperative pain, now referred to as central sensitization. Nociceptor activation is mediated by chemicals that are released in response to cellular or tissue damage. Pre-emptive analgesia is an important concept in understanding treatment strategies for postoperative analgesia. Pre-emptive analgesia focuses on postoperative pain control and the prevention of central sensitization and chronic neuropathic pain by providing analgesia administered preoperatively but not after surgical incision. Additional research in pre-emptive analgesia is warranted to better determine good outcome measurements and a better appreciation with regard to treatment optimization. Preventive analgesia reduces postoperative pain and consumption of analgesics, and this appears to be the most effective means of decreasing postoperative pain. Preventive analgesia, which includes multimodal preoperative and postoperative analgesic therapies, results in decreased postoperative pain and less postoperative consumption of analgesics.
Article
Full-text available
While laparoscopic cholecystectomy is generally considered less painful than open surgery, pain is one of the important reasons for delayed discharge after day surgery and overnight stay laparoscopic cholecystectomy. The safety and effectiveness of intraperitoneal local anaesthetic instillation in people undergoing laparoscopic cholecystectomy is unknown. To assess the benefits and harms of intraperitoneal instillation of local anaesthetic agents in people undergoing laparoscopic cholecystectomy. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and Science Citation Index Expanded to March 2013 to identify randomised clinical trials of relevance to this review. We considered only randomised clinical trials (irrespective of language, blinding, or publication status) comparing local anaesthetic intraperitoneal instillation versus placebo, no intervention, or inactive control during laparoscopic cholecystectomy for the review with regards to benefits while we considered quasi-randomised studies and non-randomised studies for treatment-related harms. Two review authors collected the data independently. We analysed the data with both fixed-effect and random-effects models using Review Manager 5 analysis. For each outcome, we calculated the risk ratio (RR) or mean difference (MD) with 95% confidence intervals (CI). We included 58 trials, of which 48 trials with 2849 participants randomised to intraperitoneal local anaesthetic instillation (1558 participants) versus control (1291 participants) contributed data to one or more of the outcomes. All the trials except one trial with 30 participants were at high risk of bias. Most trials included only low anaesthetic risk people undergoing elective laparoscopic cholecystectomy. Various intraperitoneal local anaesthetic agents were used but bupivacaine in the liquid form was the most common local anaesthetic used. There were considerable differences in the methods of local anaesthetic instillation including the location (subdiaphragmatic, gallbladder bed, or both locations) and timing (before or after the removal of gallbladder) between the trials. There was no mortality in either group in the eight trials that reported mortality (0/236 (0%) in local anaesthetic instillation versus 0/210 (0%) in control group; very low quality evidence). One participant experienced the outcome of serious morbidity (eight trials; 446 participants; 1/236 (0.4%) in local anaesthetic instillation group versus 0/210 (0%) in the control group; RR 3.00; 95% CI 0.13 to 67.06; very low quality evidence). Although the remaining trials did not report the overall morbidity, three trials (190 participants) reported that there were no intra-operative complications. Twenty trials reported that there were no serious adverse events in any of the 715 participants who received local anaesthetic instillation. None of the trials reported participant quality of life, return to normal activity, or return to work.The effect of local anaesthetic instillation on the proportion of participants discharged as day surgery between the two groups was imprecise and compatible with benefit and no difference of intervention (three trials; 242 participants; 89/160 (adjusted proportion 61.0%) in local anaesthetic instillation group versus 40/82 (48.8%) in control group; RR 1.25; 95% CI 0.99 to 1.58; very low quality evidence). The MD in length of hospital stay was 0.04 days (95% CI -0.23 to 0.32; five trials; 335 participants; low quality evidence). The pain scores as measured by the visual analogue scale (VAS) were significantly lower in the local anaesthetic instillation group than the control group at four to eight hours (32 trials; 2020 participants; MD -0.99 cm; 95% CI -1.10 to -0.88 on a VAS scale of 0 to 10 cm; very low quality evidence) and at nine to 24 hours (29 trials; 1787 participants; MD -0.53 cm; 95% CI -0.62 to -0.44; very low quality evidence). Various subgroup analyses and meta-regressions to investigate the influence of the different local anaesthetic agents, different methods of local anaesthetic instillation, and different controls on the effectiveness of local anaesthetic intraperitoneal instillation were inconsistent. Serious adverse events were rare in studies evaluating local anaesthetic intraperitoneal instillation (very low quality evidence). There is very low quality evidence that it reduces pain in low anaesthetic risk people undergoing elective laparoscopic cholecystectomy. However, the clinical importance of this reduction in pain is unknown and likely to be small. Further randomised clinical trials of low risk of systematic and random errors are necessary. Such trials should include important clinical outcomes such as quality of life and time to return to work in their assessment.
Article
Full-text available
The decision to discharge a patient undergoing day surgery is a major step in the hospitalization pathway, because it must be achieved without compromising the quality of care, thus ensuring the same assistance and wellbeing as for a long-term stay. Therefore, the use of an objective assessment for the management of a fair and safe discharge is essential. The authors propose the Post Anaesthetic Discharge Scoring System (PADSS), which considers six criteria: vital signs, ambulation, nausea/vomiting, pain, bleeding and voiding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a score of 9 or more are considered ready for discharge. Furthermore, PADSS has been modified to ensure a higher level of safety, thus the "vital signs" criteria must never score lower than 2, and none of the other five criteria must ever be equal to 0, even if the total score reaches 9. The effectiveness of PADSS was analyzed on 2432 patients, by recording the incidence of postoperative complications and the readmission to hospital. So far PADDS has proved to be an efficient system that guarantees safe discharge. KEY WORDS: Day surgery, PADSS, Safe discharge.
Article
Full-text available
With the advent of minimally invasive gastric surgery, visceral nociception has become an important area of investigation as a potential cause of postoperative pain. A systematic review and meta-analysis was carried out to investigate the clinical effects of intraperitoneal local anaesthetic (IPLA) in laparoscopic gastric procedures. Comprehensive searches were conducted independently without language restriction. Studies were identified from the following databases from inception to February 2010: Cochrane Central Register of Controlled Trials, the Cochrane Library, MEDLINE, PubMed, Embase and CINAHL. Relevant meeting abstracts and reference lists were searched manually. Appropriate methodology according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was adhered to. Five randomized controlled trials in laparoscopic gastric procedures were identified for review. There was no significant heterogeneity between the trials (χ(2) = 10·27, 10 d.f., P = 0·42, I(2) = 3 per cent). Based on meta-analysis of trials, there appeared to be reduced abdominal pain intensity (overall mean difference in pain score -1·64, 95 per cent confidence interval (c.i.) -2·09 to -1·19; P < 0·001), incidence of shoulder tip pain (overall odds ratio 0·15, 95 per cent c.i. 0·05 to 0·44; P < 0·001) and opioid use (overall mean difference -3·23, -4·81 to -1·66; P < 0·001). There is evidence in favour of IPLA in laparoscopic gastric procedures for reduction of abdominal pain intensity, incidence of shoulder pain and postoperative opioid consumption.
Article
Full-text available
To examine the combined preemptive effects of somatovisceral blockade during laparoscopic cholecystectomy (LC). One hundred fifty-seven patients under general anesthesia receiving local infiltration and/or topical peritoneal local anesthesia were studied. Patients were randomized to receive a total of 150 mg (0.25% 60 mL) bupivacaine via periportal (20 mL) and intraperitoneal (40 mL with 1:200,000 epinephrine) administration of each. Group A received preoperative periportal bupivacaine before incision and intraperitoneal bupivacaine immediately after the pneumoperitoneum. Group B received periportal and intraperitoneal bupivacaine at the end of the operation. Group C (preoperative) and Group D (postoperative) received only periportal bupivacaine and Group E (preoperative) and Group F (post-operative) received only intraperitoneal bupivacaine. The control group received no treatment. Pain and nausea were recorded at one, two, three, six, nine, 12, 24, 36, and 48 hr postoperatively. Throughout the postoperative 48 hr, incisional somatic pain dominated over other pain localizations in the control group (P <0.05). The incisional pain of groups A, B, C and D was significantly lower than that of the control group in the first and second hours. The incisional pain of groups A and C was significantly lower than that of the control group in the first three hours. Incisional pain dominated during the first two post-operative days after LC. Preoperative somato-visceral or somatic local anesthesia reduced incisional pain during the first three post-operative hours. A combination of somato-visceral local anesthetic treatment did not reduce intraabdominal pain, shoulder pain or nausea more than somatic treatment alone. Preoperative incisional infiltration of local anesthetics is recommended.
Article
Objective: This study aimed to compare the efficacy of local anaesthetic infiltration to trocar wounds and intraperitoneally on postoperative pain as a part of a multimodal analgesia method after laparoscopic cholecystectomies. Methods: The study was performed on 90 ASA I-III patients aged between 20 and 70 years who underwent elective laparoscopic cholecystectomy. All patients had the same general anaesthesia drug regimen. Patients were randomized into three groups by a closed envelope method: group I (n=30), trocar site local anaesthetic infiltration (20 mL of 0.5% bupivacaine); group II (n=30), intraperitoneal local anaesthetic instillation (20 mL of 0.5%) and group III (n=30), saline infiltration both trocar sites and intraperitoneally. Postoperative i.v. patient controlled analgesia was initiated for 24 h. In total, 4 mg of i.v. ondansetron was administered to all patients. Visual analogue scale (VAS), nausea and vomiting and shoulder pain were evaluated at 1., 2., 4., 8., 12., 24. hours. An i.v. nonsteroidal anti-inflammatory drug (NSAID) (50 mg of dexketoprofen) as a rescue analgesic was given if the VAS was ≥5. Results: There were no statistical significant differences between the clinical and demographic properties among the three groups (p≥0.005). During all periods, VAS in group I was significantly lower than that in groups II and III (p<0.001). Among the groups, although there was no significant difference in nausea and vomiting (p=0.058), there was a significant difference in shoulder pain. Group III (p<0.05) had more frequent shoulder pain than groups I and II. The total morphine consumption was higher in groups II and III (p<0.001 vs p<0.001) than in group I. The requirement for a rescue analgesic was significantly higher in group III (p<0.05). Conclusion: Trocar site local anaesthetic infiltration is more effective for postoperative analgesia, easier to apply and safer than other analgesia methods. Morphine consumption is lesser and side effects are fewer; therefore, this method can be used as a part of common practice.
Article
Acute pain after laparoscopic cholecystectomy is complex in nature. The pain pattern does not resemble pain after other laparoscopic procedures, suggesting that analgesic treatment might be procedure specific and multimodal. Randomized trials of analgesia after laparoscopic cholecystectomy were identified by systematic electronic literature searches (1985 to June 2005) supplemented with manual searching. The trials were categorized by well-defined criteria into high, moderate, or poor methodologic quality. Conclusions were based on trials of high and moderate methodologic quality. In total, 64 randomized analgesic trials were identified, comprising a total of 5,018 evaluated patients. The literature suggests a multimodal analgesic regimen consisting of a preoperative single dose of dexamethasone, incisional local anesthetics (at the beginning or at the end of surgery, depending on preference), and continuous treatment with nonsteroidal antiinflammatory drugs (or cyclooxygenase-2 inhibitors) during the first 3-4 days. Opioids should be used only when other analgesic techniques fail.
Article
Background: This study aimed to evaluate the optimal timing of preemptive analgesia with bupivacaine peritoneal instillation in a prospective, randomized, double-blind, placebo-controlled trial. Methods: In this study, 120 patients qualified for laparoscopic cholecystectomy were randomized to four groups. Group A received 2 mg/kg of bupivacaine in 200 ml of normal saline before creation of pneumoperitoneum. Group B received 2 mg/kg of bupivacaine in 200 ml of normal saline after creation of pneumoperitoneum. Group C received 200 ml of normal saline before creation of pneumoperitoneum. Group D received 200 ml of normal saline after creation of pneumoperitoneum. Local wound infiltration with bupivacaine was used before skin incisions. The primary end points of the study were postoperative pain intensity on a visual analog scale and incidence of shoulder tip pain. The secondary end points included the latency of nurse-controlled analgesia activation, the analgesia request rate, and analgesic consumption. Results: Significantly lower visual analog scores were observed in group A versus groups C and B versus group D during the initial 48 and 24 h, respectively. The patients in group A versus group B reported significantly lower pain at 4 h (p < 0.001) and 8 h (p = 0.003) postoperatively, but the difference was not significant after 12, 24, and 48 h. None of the group A patients reported shoulder tip pain, whereas it was reported by 3 patients in group B, 6 patients in group C, and 7 patients in group D (p < 0.01). The latency of nurse-controlled analgesia activation was 426.8 +/-57.2 min in group A, as compared with 307 +/- 39.8 min in group B, 109.3 +/- 51 min in group C, and 109 +/- 46.5 min in group D (p < 0.001). A significantly lower analgesia request rate was observed in group A versus C, as compared with group B versus D, throughout the entire study period (p < 0.05). Conclusions: Preemptive analgesia with bupivacaine peritoneal instillation is much more effective for pain relief if used before creation of pneumoperitoneum. Although the effect of bupivacaine peritoneal instillation is also noticeable when used after creation of pneumoperitoneum, it confers significantly lower benefits.